Is tailoring treatment of rectal cancer the only true benefit of long-course neoadjuvant chemoradiation? Another view

Simon P. Bach*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)267-270
Number of pages4
JournalDiseases of the Colon and Rectum
Volume56
Issue number2
DOIs
Publication statusPublished - Feb 2013

ASJC Scopus subject areas

  • Gastroenterology

Cite this